Amgen (Netherlands)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 13 papers

  • Book Chapter

Circular economy and life cycle management

  • Jan 01, 2025
  • Margaret M Faul +5
  • Book Chapter

Conclusions and Way Forward

  • Jan 01, 2025
  • Jaap M De Heer +1
  • Book Chapter

Need of up to Date Data and Knowledge

  • Jan 01, 2025
  • Jaap M De Heer +1
  • Research Article
  • Citations12

Phase 1 clinical trial of AMG 340, a prostate-specific membrane antigen (PSMA)-targeted T-cell engager with a novel low-affinity CD3 binding domain designed to mitigate toxicity for the treatment of metastatic castration-resistant prostate cancer (mCRPC).

  • Jun 01, 2024
  • Journal of Clinical Oncology
  • Gerald Steven Falchook +11
  • Open Access
  • Research Article

Characteristics of patients initiating PCSK9i mAb following myocardial infarction and comparability of treatment groups in the Netherlands

  • Nov 09, 2023
  • European Heart Journal
  • Q Chan +13
  • Conference Article
  • Citations9

Continuous Quasi-Load Insensitive Class-E Mode for Wideband Doherty Power Amplifiers

  • Jun 11, 2023
  • Xuan Anh Nghiem +1
  • Open Access
  • Research Article
  • Citations3

Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not

  • Jul 31, 2020
  • Clinical Pharmacology : Advances and Applications
  • Michael Z Liao +4
  • Open Access
  • Research Article
  • Citations20

Power‐efficient full‐duplex K/Ka‐band phased array front‐end

  • Feb 13, 2020
  • IET Microwaves, Antennas & Propagation
  • Filipe Tabarani +4
  • Open Access
  • Research Article
  • Citations740

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.

  • Mar 01, 2016
  • Journal of the National Comprehensive Cancer Network
  • David S Ettinger +35
  • Open Access
  • Research Article
  • Citations35

A comparative study of the role of disease severity in drug reimbursement decision making in four European countries

  • Oct 22, 2014
  • Health Policy
  • Margreet Franken +4
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.